These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38720287)

  • 1. Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
    Tsukadaira T; Hayashi S; Ota H; Kobayashi N; Agawa H; Kodaira H; Sekiguchi Y; Matsumoto T; Horiuchi K; Negishi T; Tada T
    BMC Gastroenterol; 2024 May; 24(1):157. PubMed ID: 38720287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pylori Helicobacters in Helicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen.
    Nakamura M; Øverby A; Michimae H; Matsui H; Takahashi S; Mabe K; Shimoyama T; Sasaki M; Terao S; Kamada T; Yanaka A; Iwamoto J; Tanabe S; Tari A; Nasu S; Suzuki H; Yamagata Murayama S
    Helicobacter; 2020 Oct; 25(5):e12700. PubMed ID: 32790220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
    Takigawa H; Masaki S; Naito T; Yuge R; Urabe Y; Tanaka S; Sentani K; Matsuo T; Matsuo K; Chayama K; Kitadai Y
    Cancer Med; 2019 Aug; 8(9):4370-4379. PubMed ID: 31210418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
    Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
    Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.
    van Zanten SV; Desai S; Best L; Cooper-Lesins G; Malatjalian D; Haldane D; Peltekian K
    Can J Gastroenterol; 2010 May; 24(5):303-6. PubMed ID: 20485704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
    Dib J; Alvarez B; Mendez L; Cruz ME
    Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
    Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
    Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Helicobacter suis infection in a pig veterinarian.
    Joosten M; Flahou B; Meyns T; Smet A; Arts J; De Cooman L; Pasmans F; Ducatelle R; Haesebrouck F
    Helicobacter; 2013 Oct; 18(5):392-6. PubMed ID: 23551953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
    Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
    P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication.
    Kusunoki M; Yuki M; Ishitobi H; Kobayashi Y; Nagaoka M; Takahashi Y; Fukuba N; Komazawa Y; Shizuku T; Kinoshita Y
    Intern Med; 2019 Jun; 58(11):1549-1555. PubMed ID: 30713328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
    Sezgin O; Aydın MK; Özdemir AA; Kanık AE
    Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
    J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical features, and esophagogastroduodenoscopy (EGD) findings of non-Helicobacter pylori Helicobacter infection: A study of 50 cases at a single facility in Japan.
    Tsukadaira T; Hayashi S; Ota H; Kobayashi N; Sekiguchi Y; Kodaira H; Matsumoto T; Horiuchi K; Negishi T; Kurahashi M
    Helicobacter; 2021 Aug; 26(4):e12811. PubMed ID: 33908121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
    Prasertpetmanee S; Mahachai V; Vilaichone RK
    Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.